News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

 

The New England Journal of Medicine Publishes Phase I Data on Glivec, An Investigational Anti-Cancer Therapy (PR Newswire)...Also featured in this issue of the NEJM is a case history of the treatment of a patient with a gastrointestinal stromal tumor (GIST).......GISTs are solid tumors that express an activated protein shown to be inhibited by Glivec.......including hormone refractory prostate cancer, gliomas (a cancer of the brain) and small-cell lung cancer....- Apr 04 5:00 PM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010404/nyw102.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740